This study investigates pancreatic cancer. The purpose of this study is to evaluate the safety and clinical activity of two different investigational vaccines used in combination with other treatments for individuals with surgically resectable pancreatic adenocarcinoma.
The study focuses on determining how safe these investigational vaccines are and how well they work when used together with other treatments. It evaluates the safety and effectiveness of these combinations in individuals with pancreatic cancer.
- Who can participate: Adults diagnosed with pancreatic adenocarcinoma that can be surgically removed may join. Participants should have a good performance status and must not have received any prior anti-cancer immunotherapy.
- Study details: Participants will receive investigational vaccines in combination with other treatments. Some may receive a placebo, which is an inactive substance that looks like the investigational vaccine but does not contain any medicine.
How understandable was the trial content above?
Hard to understand
Easy to understand